Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at intensive treatment and ponatinib for chronic myeloid leukaemia (MATCHPOINT)

Overview

Cancer types:

Blood cancers, Chronic leukaemia, Chronic myeloid leukaemia (CML), Leukaemia

Status:

Closed

Phase:

Phase 1

Details

This trial is looking at high dose chemotherapy and a stem cell transplant alongside a drug called ponatinib for chronic myeloid leukaemia (CML). It is for people whose CML is now in blast phase. This means you have a lot of immature cells called blasts in your blood and .

Recruitment start: 2 December 2014

Recruitment end: 26 April 2018

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Mhairi Copland

Supported by

ARIAD Pharmaceuticals Inc

Bloodwise TAP

Experimental Cancer Medicine Centre (ECMC)

University of Birmingham

Last reviewed: 24 May 2018

CRUK internal database number: 10476

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.